NO884329D0 - Fremgangsmaate for fremstilling av vannfritt, krystallinsk natriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid. - Google Patents

Fremgangsmaate for fremstilling av vannfritt, krystallinsk natriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid.

Info

Publication number
NO884329D0
NO884329D0 NO1988884329A NO884329A NO884329D0 NO 884329 D0 NO884329 D0 NO 884329D0 NO 1988884329 A NO1988884329 A NO 1988884329A NO 884329 A NO884329 A NO 884329A NO 884329 D0 NO884329 D0 NO 884329D0
Authority
NO
Norway
Prior art keywords
crystallic
oxindol
tenoyl
carboxamide
annual
Prior art date
Application number
NO1988884329A
Other languages
English (en)
Other versions
NO170581B (no
NO884329L (no
NO170581C (no
Inventor
Douglas John Meldrum Allen
Brian Thomas O'neill
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of NO884329L publication Critical patent/NO884329L/no
Publication of NO884329D0 publication Critical patent/NO884329D0/no
Publication of NO170581B publication Critical patent/NO170581B/no
Publication of NO170581C publication Critical patent/NO170581C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO88884329A 1987-02-02 1988-09-29 Fremgangsmaate for fremstilling av vannfritt, krystallinsknatriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid NO170581C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (4)

Publication Number Publication Date
NO884329L NO884329L (no) 1988-09-29
NO884329D0 true NO884329D0 (no) 1988-09-29
NO170581B NO170581B (no) 1992-07-27
NO170581C NO170581C (no) 1992-11-04

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884329A NO170581C (no) 1987-02-02 1988-09-29 Fremgangsmaate for fremstilling av vannfritt, krystallinsknatriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid

Country Status (42)

Country Link
US (1) US5036099A (no)
EP (1) EP0277738B1 (no)
JP (1) JPS63201184A (no)
KR (1) KR900001422B1 (no)
CN (1) CN1022324C (no)
AP (1) AP52A (no)
AR (1) AR243182A1 (no)
AT (1) ATE73800T1 (no)
AU (1) AU587736B2 (no)
BG (1) BG51042A3 (no)
CA (1) CA1335590C (no)
CS (2) CS265250B2 (no)
CY (1) CY1775A (no)
DD (1) DD267490A5 (no)
DE (1) DE3869149D1 (no)
DK (1) DK44888A (no)
EC (1) ECSP941082A (no)
ES (1) ES2032955T3 (no)
FI (1) FI89598C (no)
GR (1) GR3004200T3 (no)
HK (1) HK132695A (no)
IE (1) IE60000B1 (no)
IL (1) IL85277A (no)
IN (1) IN171799B (no)
IS (1) IS1533B (no)
LV (1) LV10252B (no)
MA (1) MA21171A1 (no)
MY (1) MY102737A (no)
NO (1) NO170581C (no)
NZ (1) NZ223373A (no)
OA (1) OA08710A (no)
PH (1) PH26545A (no)
PL (1) PL149550B1 (no)
PT (1) PT86675B (no)
RO (1) RO105052B1 (no)
RU (1) RU2011381C1 (no)
SG (1) SG27994G (no)
SI (1) SI8810183A8 (no)
UA (1) UA25898A1 (no)
WO (1) WO1988005656A1 (no)
YU (1) YU46766B (no)
ZA (1) ZA88679B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
SK590689A3 (en) * 1988-10-18 1996-03-06 Pfizer 3-aryl-2-oxindole-1-carboxamides and method of their preparation
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
KR20200085285A (ko) 2017-11-02 2020-07-14 애커러트 메디컬 테라퓨틱스 엘티디. 필터가 내장된 색전술용 카테터

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
ATE63543T1 (de) * 1984-02-07 1991-06-15 Pfizer 2-oxindolzwischenprodukte.
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3579716D1 (de) * 1984-03-19 1990-10-25 Pfizer Verfahren zur herstellung von 2-oxindole-1-carboxamiden und deren zwischenprodukte.
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
AP8800081A0 (en) 1987-11-01
FI893647A0 (fi) 1989-08-01
JPH0576945B2 (no) 1993-10-25
IE880269L (en) 1988-08-02
CS354191A3 (en) 1992-04-15
ZA88679B (en) 1989-09-27
AR243182A1 (es) 1993-07-30
IS3309A7 (is) 1988-08-03
UA25898A1 (uk) 1999-02-26
CA1335590C (en) 1995-05-16
PH26545A (en) 1992-08-19
CS64888A2 (en) 1988-08-16
AU1116088A (en) 1988-08-04
IL85277A (en) 1994-02-27
NO170581B (no) 1992-07-27
MY102737A (en) 1992-09-30
SG27994G (en) 1994-10-14
AP52A (en) 1989-09-16
IS1533B (is) 1994-01-28
EP0277738B1 (en) 1992-03-18
CN1022324C (zh) 1993-10-06
RO105052B1 (en) 1994-12-01
BG51042A3 (en) 1993-01-15
YU18388A (en) 1989-10-31
NO884329L (no) 1988-09-29
KR880009961A (ko) 1988-10-06
YU46766B (sh) 1994-05-10
PL149550B1 (en) 1990-02-28
DK44888A (da) 1988-08-03
DD267490A5 (de) 1989-05-03
AU587736B2 (en) 1989-08-24
MA21171A1 (fr) 1988-10-01
IN171799B (no) 1993-01-09
IL85277A0 (en) 1988-07-31
KR900001422B1 (ko) 1990-03-09
PT86675A (pt) 1988-03-01
PT86675B (pt) 1992-07-31
SI8810183A8 (sl) 1996-08-31
OA08710A (fr) 1989-03-31
DK44888D0 (da) 1988-01-29
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
GR3004200T3 (no) 1993-03-31
ES2032955T3 (es) 1996-07-16
CY1775A (en) 1996-04-05
FI89598B (fi) 1993-07-15
PL270415A1 (en) 1988-12-08
CN88100555A (zh) 1988-08-17
EP0277738A1 (en) 1988-08-10
IE60000B1 (en) 1994-05-18
ECSP941082A (es) 1994-12-15
NZ223373A (en) 1989-06-28
HK132695A (en) 1995-09-01
ATE73800T1 (de) 1992-04-15
RU2011381C1 (ru) 1994-04-30
FI89598C (fi) 1993-10-25
LV10252A (lv) 1994-10-20
DE3869149D1 (de) 1992-04-23
CS265250B2 (en) 1989-10-13
US5036099A (en) 1991-07-30
NO170581C (no) 1992-11-04
WO1988005656A1 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
NO884329D0 (no) Fremgangsmaate for fremstilling av vannfritt, krystallinsk natriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid.
NO842273L (no) Fremgangsmaate ved fremstilling av aminomethyloxooxazolidinylbenzenderivater.
ES545810A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES538231A0 (es) Procedimiento para la preparacion de derivado de esfingosina.
ES538464A0 (es) Procedimiento para la preparacion de derivados de acilamida.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
AR240460A1 (es) Procedimeitno para la preparacion de derivados de antraciclina.
NO884900D0 (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
AR240317A1 (es) Procedimiento para la preparacion de pirimidinatrionas n-monosubtituidas-5,5-disubtituidas.
NO882655L (no) Fremgangsmaate for fremstilling av (e)-2-(p-fluorfenethyl)-3-fluorallylamin.
NO154696C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte difenylazometinderivater.
ES536424A0 (es) Procedimiento para la preparacion de derivados d,l-d- y l-del acido 3-imidazolil-2-amino-propionico.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
NO870889D0 (no) Fremgangsmaate for fremstilling av aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater.
ES533185A0 (es) Procedimiento para la preparacion de nuevos derivados de 2-propanol.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO842480L (no) Fremgangsmaate for fremsilling av antibakterielle 2-alkyltiopenem-derivater.
ES523388A0 (es) Procedimiento de preparacion de sulfoxidos de derivados de la tioformamida.
NO862648D0 (no) Fremgangsmaate for fremstilling av farenakologisk aktive 2-substituerte-3,4-dibydroksyfenyletylamino-derivater.
IT8421696A0 (it) Procedimento per la preparazione di 29-idrossi-3,11-dimetil-2-nonacosanone.
NO167804C (no) Fremgangsmaate for fremstilling av 1-substituert-fenyl-1,4-dihydro-4-oksonaftyridin-derivater.
MX13201A (es) Procedimiento para la preparacion de 4-aril-5carbamoil-1,4-dihidro-piridinas.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees